Nikos Tsoulos, MSc, MBA, PhDc
Biochemist, CEO, GeneKor Medical SA
Nikos Tsoulos studied Biochemistry and graduated with honors from New York State University at Stony Brook. He has worked as a Biochemist at the research laboratory of Capital Genomics Inc. in Maryland at USA.
As CEO, Nikos Tsoulos has created GeneKor’s commercial department establishing, at the same time, a series of partnerships with international organizations (Oncotype DX, miRview Foundation One, Molecular Intelligence and PCA3).
To this day, he has managed to develop an wide network in Europe, the Middle East and the Balkans providing molecular analyses focusing on focusing on high quality, accessibility, reliability and immediate results.
Currently, he is completing his PhD degree, which is focused on hereditary breast and ovarian cancer and the title of his dissertation is “Hereditary Breast and Ovarian Cancer in Relation with WES and Polygenic Risk Score.”
Nikos Tsoulos has also been the Vice President of the Research Institute of Individualized Medicine for Cancer, a non-profit organization.